Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06734572 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study

Name: 18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study — clinical trial record (NCT06734572)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseEarly Phase 1

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2024-06-25

View on ClinicalTrials.gov ↗

Record status

This record was last updated December 16, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

As a new dual targeting PET radiotracer, 18F-FAPI-Biotin is promising as an excellent imaging agent applicable to various cancers. In this study, we observed the safety, biodistribution and radiation dosimetry of 18F-FAPI-Biotin in patients with various types of cancer and compared them with the results of 18F-FAPI or 18F-FDG imaging to evaluate the dosimetric characteristics and diagnostic efficacy of 18F-FAPI.

Trial Details

NCT Number	NCT06734572
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Malignant Neoplasm
Enrollment	5 participants
Start Date	2024-06-25
Primary Completion	2025-10-01 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-12-16